1.Rousseaux, A., et al. (2021). Human Milk Oligosaccharides: Their Effects on the Host and Their Potential as Therapeutic Agents. Frontiers in Immunology, 12, Article 801911.

2.Lacto-N-neotetraose. PubChem; National Center for Biotechnology Information. https://pubchem.ncbi.nlm.nih.gov/compound/121853 (accessed 2025-09-01).

3.Kobata, A. (2010). Structures and application of oligosaccharides in human milk. Proceedings of the Japan Academy, Series B, 86(7), 731–747.

4.Thurl, S., et al. (2017). Variation of human milk oligosaccharides in relation to milk groups and lactational periods. British Journal of Nutrition, 104(9), 1261–1271.

5.Elison, E., et al. (2016). Oral supplementation of healthy adults with 2′-O-fucosyllactose and lacto-N-neotetraose is well tolerated and shifts the intestinal microbiota. The American Journal of Clinical Nutrition, 104(3), 1001–1009.

6.鉴定结果来源于第三方机构，2025年《符合性验证证书》，2023年《2'-FL 化学结构等同性实验》；分析数据来源于各公司GRAS申报数据。